- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently seeking a Global Oncology Business… more
- Daiichi Sankyo, Inc. (Philadelphia, PA)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary: The Oncology Clinical Educator role provides… more
- Cipla (Fall River, MA)
- …with focus on a range of therapeutic areas, including cardiovascular , anti-infective, CNS, anti-inflammatory, anti-diabetic, and anti-depressants. The company was ... founded in 2003 and is based in Central Islip and Hauppauge, New York. As of February 18, 2016, InvaGen Pharmaceuticals, Inc. operates as a subsidiary of Cipla (EU) Limited. EEO Statement: Cipla is an Equal Opportunity Employer. All qualified applicants will… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently seeking a US Marketing Intern for Summer… more
- Novo Nordisk Inc. (Irvine, CA)
- …class therapies for the treatment of diabetes, obesity, and the reduction of adverse cardiovascular events. As part of the team, you will have frontline exposure to ... our portfolio vision, business strategies, and critical market insights that drive our business forward. You will drive the NNI portfolio strategy in tandem with our marketing team, and balance performance with compassion to ensure that the latest therapies… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently seeking a OBD Training & Development… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently seeking an IT Risk & Security Governance… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently seeking an IT Infrastructure and… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently seeking a Global DX Project Assurance… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator ... with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. We are currently seeking an R&D Operations Intern for… more
